{"transactions":[{"id":3836276,"issuer":{"id":108116,"kind":"organization","name":"Acer Therapeutics Inc.","symbol":"ACER"},"owners":[{"id":164099,"kind":"person","name":"TVM Life Science Ventures VII L.P.","position":1,"cik":"0001640880","reported_name":"TVM Life Science Ventures VII L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164100,"kind":"person","name":"Birner Hubert","position":2,"cik":"0001398598","reported_name":"Birner Hubert","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164101,"kind":"person","name":"Marengere Luc","position":3,"cik":"0001639971","reported_name":"Marengere Luc","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164102,"kind":"person","name":"Fischer Stefan","position":4,"cik":"0001398596","reported_name":"Fischer Stefan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164103,"kind":"person","name":"SCHUHSLER HELMUT","position":5,"cik":"0001133921","reported_name":"SCHUHSLER HELMUT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164104,"kind":"person","name":"Beeby Reshentha","position":6,"cik":"0001750983","reported_name":"Beeby Reshentha","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164105,"kind":"person","name":"Leatt Gary","position":7,"cik":"0001718117","reported_name":"Leatt Gary","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-22T16:22:11.000Z","date":"2018-08-01","kind":"purchase","acquired":true,"shares":275000,"price":18,"value":4950000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are directly held by TVM Life Science Ventures VII L.P. (\"TVM VII LP\"). TVM Life Science Ventures VII (GP) Ltd. (\"TVM VII GP Ltd\") is the general partner of TVM VII LP. Hubert Birner (\"Birner\"), Stefan Fischer (\"Fischer\"), Helmut Schuhsler (\"Schuhsler\"), Luc Marengere (\"Marengere\"), Reshentha Beeby (\"Beeby\"), and Gary Leatt (\"Leatt\") are members of the investment committee of TVM VII GP Ltd, which has voting and investment power with respect to these shares. TVM VII GP Ltd, Birner, Fischer, Schuhsler, Marengere, Beeby and Leatt each disclaim any beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein, if any. Marengere is a director of the Issuer."}],"balance_after":1697709,"source":{"system":"sec-edgar","filing":"0001012975-18-001040","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069308/000101297518001040/edgar.xml","form_type":"4"}},{"id":4100692,"issuer":{"id":108116,"kind":"organization","name":"Acer Therapeutics Inc.","symbol":"ACER"},"owners":[{"id":170324,"kind":"person","name":"TVM Life Science Ventures VI GmbH & Co KG","position":1,"cik":"0001599744","reported_name":"TVM Life Science Ventures VI GmbH & Co KG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":170325,"kind":"person","name":"TVM Life Science Ventures VI LP","position":2,"cik":"0001318584","reported_name":"TVM Life Science Ventures VI LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164099,"kind":"person","name":"TVM Life Science Ventures VII L.P.","position":3,"cik":"0001640880","reported_name":"TVM Life Science Ventures VII L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164100,"kind":"person","name":"Birner Hubert","position":4,"cik":"0001398598","reported_name":"Birner Hubert","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164101,"kind":"person","name":"Marengere Luc","position":5,"cik":"0001639971","reported_name":"Marengere Luc","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164102,"kind":"person","name":"Fischer Stefan","position":6,"cik":"0001398596","reported_name":"Fischer Stefan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164103,"kind":"person","name":"SCHUHSLER HELMUT","position":7,"cik":"0001133921","reported_name":"SCHUHSLER HELMUT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":170326,"kind":"person","name":"Wanless Mark","position":8,"cik":"0001718086","reported_name":"Wanless Mark","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164105,"kind":"person","name":"Leatt Gary","position":9,"cik":"0001718117","reported_name":"Leatt Gary","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-12T14:33:26.000Z","date":"2017-12-12","kind":"purchase","acquired":true,"shares":250000,"price":12,"value":3000000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are directly held by TVM Life Science Ventures VII L.P. (\"TVM VII LP\"). TVM Life Science Ventures VII (GP) Ltd. (\"TVM VII GP Ltd\") is the general partner of TVM VII LP. Luc Marengere (\"Marengere\"), Mark Wanless (\"Wanless\"), Gary Leatt (\"Leatt\"), Birner, Fischer and Schuhsler are members of the investment committee of TVM VII GP Ltd, which has voting and investment power with respect to these shares. TVM VII GP Ltd, Birner, Fischer, Schuhsler, Marengere, Wanless and Leatt each disclaim any beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein, if any. Marengere is a director of the Issuer."}],"balance_after":1422709,"source":{"system":"sec-edgar","filing":"0001012975-18-000059","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069308/000101297518000059/edgar.xml","form_type":"4"}},{"id":4100691,"issuer":{"id":108116,"kind":"organization","name":"Acer Therapeutics Inc.","symbol":"ACER"},"owners":[{"id":170324,"kind":"person","name":"TVM Life Science Ventures VI GmbH & Co KG","position":1,"cik":"0001599744","reported_name":"TVM Life Science Ventures VI GmbH & Co KG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":170325,"kind":"person","name":"TVM Life Science Ventures VI LP","position":2,"cik":"0001318584","reported_name":"TVM Life Science Ventures VI LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164099,"kind":"person","name":"TVM Life Science Ventures VII L.P.","position":3,"cik":"0001640880","reported_name":"TVM Life Science Ventures VII L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164100,"kind":"person","name":"Birner Hubert","position":4,"cik":"0001398598","reported_name":"Birner Hubert","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164101,"kind":"person","name":"Marengere Luc","position":5,"cik":"0001639971","reported_name":"Marengere Luc","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164102,"kind":"person","name":"Fischer Stefan","position":6,"cik":"0001398596","reported_name":"Fischer Stefan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164103,"kind":"person","name":"SCHUHSLER HELMUT","position":7,"cik":"0001133921","reported_name":"SCHUHSLER HELMUT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":170326,"kind":"person","name":"Wanless Mark","position":8,"cik":"0001718086","reported_name":"Wanless Mark","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164105,"kind":"person","name":"Leatt Gary","position":9,"cik":"0001718117","reported_name":"Leatt Gary","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-12T14:33:26.000Z","date":"2017-12-12","kind":"purchase","acquired":true,"shares":21271,"price":12,"value":255252.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by TVM Life Science Ventures VI L.P. (\"TVM VI LP\"). Birner, Schuhsler and Fischer are members of the investment committee of TVM VI Management, a special limited partner of TVM VI LP, with voting and dispositive power over the shares held by TVM VI LP. TVM VI Management, Birner, Schuhsler and Fischer each disclaim beneficial ownership of the shares held by TVM VI LP, except to the extent of any pecuniary interest therein, if any."}],"balance_after":248756,"source":{"system":"sec-edgar","filing":"0001012975-18-000059","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069308/000101297518000059/edgar.xml","form_type":"4"}},{"id":4100690,"issuer":{"id":108116,"kind":"organization","name":"Acer Therapeutics Inc.","symbol":"ACER"},"owners":[{"id":170324,"kind":"person","name":"TVM Life Science Ventures VI GmbH & Co KG","position":1,"cik":"0001599744","reported_name":"TVM Life Science Ventures VI GmbH & Co KG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":170325,"kind":"person","name":"TVM Life Science Ventures VI LP","position":2,"cik":"0001318584","reported_name":"TVM Life Science Ventures VI LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164099,"kind":"person","name":"TVM Life Science Ventures VII L.P.","position":3,"cik":"0001640880","reported_name":"TVM Life Science Ventures VII L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164100,"kind":"person","name":"Birner Hubert","position":4,"cik":"0001398598","reported_name":"Birner Hubert","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164101,"kind":"person","name":"Marengere Luc","position":5,"cik":"0001639971","reported_name":"Marengere Luc","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164102,"kind":"person","name":"Fischer Stefan","position":6,"cik":"0001398596","reported_name":"Fischer Stefan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164103,"kind":"person","name":"SCHUHSLER HELMUT","position":7,"cik":"0001133921","reported_name":"SCHUHSLER HELMUT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":170326,"kind":"person","name":"Wanless Mark","position":8,"cik":"0001718086","reported_name":"Wanless Mark","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164105,"kind":"person","name":"Leatt Gary","position":9,"cik":"0001718117","reported_name":"Leatt Gary","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-12T14:33:26.000Z","date":"2017-12-12","kind":"purchase","acquired":true,"shares":62062,"price":12,"value":744744.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by TVM Life Science Ventures VI GmbH & Co. KG (\"TVM VI\"). Hubert Birner (\"Birner\"), Stefan Fischer (\"Fischer\"), and Helmut Schuhsler (\"Schuhsler\") are members of the investment committee of TVM Life Science Ventures Management VI L.P. (\"TVM VI Management\"), a special limited partner of TVM VI, with voting and dispositive power over the shares held by TVM VI. TVM VI Management, Birner, Schuhsler and Fischer each disclaim beneficial ownership of the shares held by TVM VI, except to the extent of any pecuniary interest therein, if any. Birner is a director of the Issuer."}],"balance_after":725844,"source":{"system":"sec-edgar","filing":"0001012975-18-000059","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069308/000101297518000059/edgar.xml","form_type":"4"}},{"id":4201071,"issuer":{"id":108116,"kind":"organization","name":"Acer Therapeutics Inc.","symbol":"ACER"},"owners":[{"id":170324,"kind":"person","name":"TVM Life Science Ventures VI GmbH & Co KG","position":1,"cik":"0001599744","reported_name":"TVM Life Science Ventures VI GmbH & Co KG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":170325,"kind":"person","name":"TVM Life Science Ventures VI LP","position":2,"cik":"0001318584","reported_name":"TVM Life Science Ventures VI LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164099,"kind":"person","name":"TVM Life Science Ventures VII L.P.","position":3,"cik":"0001640880","reported_name":"TVM Life Science Ventures VII L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164100,"kind":"person","name":"Birner Hubert","position":4,"cik":"0001398598","reported_name":"Birner Hubert","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164101,"kind":"person","name":"Marengere Luc","position":5,"cik":"0001639971","reported_name":"Marengere Luc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164102,"kind":"person","name":"Fischer Stefan","position":6,"cik":"0001398596","reported_name":"Fischer Stefan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164103,"kind":"person","name":"SCHUHSLER HELMUT","position":7,"cik":"0001133921","reported_name":"SCHUHSLER HELMUT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":170326,"kind":"person","name":"Wanless Mark","position":8,"cik":"0001718086","reported_name":"Wanless Mark","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164105,"kind":"person","name":"Leatt Gary","position":9,"cik":"0001718117","reported_name":"Leatt Gary","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-27T18:34:28.000Z","date":"2017-09-19","kind":"other","acquired":true,"shares":1172709,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired pursuant to an Agreement and Plan of Merger, dated as of June 30, 2017 (the \"Merger Agreement\"), pursuant to which a wholly-owned subsidiary of the Issuer merged with and into Acer Therapeutics Inc. (\"Acer\"). Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement) of the closing of the Mergers contemplated thereby, the then outstanding shares of Acer's common stock were cancelled and were automatically converted into the right to receive 1 share of the Issuer's common stock for each share of Acer common stock then held by the Reporting Persons. These shares were previously reported on a Form 3 filed by the Reporting Persons on the date of this filing."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were acquired pursuant to an Agreement and Plan of Merger, dated as of June 30, 2017 (the \"Merger Agreement\"), pursuant to which a wholly-owned subsidiary of the Issuer merged with and into Acer Therapeutics Inc. (\"Acer\"). Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement) of the closing of the Mergers contemplated thereby, the then outstanding shares of Acer's common stock were cancelled and were automatically converted into the right to receive 1 share of the Issuer's common stock for each share of Acer common stock then held by the Reporting Persons. These shares were previously reported on a Form 3 filed by the Reporting Persons on the date of this filing."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are directly held by TVM Life Science Ventures VII L.P. (\"TVM VII LP\"). TVM Life Science Ventures VII (GP) Ltd. (\"TVM VII GP Ltd\") is the general partner of TVM VII LP. Luc Marengere (\"Marengere\"), Mark Wanless (\"Wanless\"), Gary Leatt (\"Leatt\"), Birner, Fischer and Schuhsler are members of the investment committee of TVM VII GP Ltd, which has voting and investment power with respect to these shares. TVM VII GP Ltd, Birner, Fischer, Schuhsler, Marengere, Wanless and Leatt each disclaim any beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein, if any. Marengere is a director of the Issuer."}],"balance_after":1172709,"source":{"system":"sec-edgar","filing":"0001012975-17-000726","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069308/000101297517000726/edgar.xml","form_type":"4"}},{"id":4201070,"issuer":{"id":108116,"kind":"organization","name":"Acer Therapeutics Inc.","symbol":"ACER"},"owners":[{"id":170324,"kind":"person","name":"TVM Life Science Ventures VI GmbH & Co KG","position":1,"cik":"0001599744","reported_name":"TVM Life Science Ventures VI GmbH & Co KG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":170325,"kind":"person","name":"TVM Life Science Ventures VI LP","position":2,"cik":"0001318584","reported_name":"TVM Life Science Ventures VI LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164099,"kind":"person","name":"TVM Life Science Ventures VII L.P.","position":3,"cik":"0001640880","reported_name":"TVM Life Science Ventures VII L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164100,"kind":"person","name":"Birner Hubert","position":4,"cik":"0001398598","reported_name":"Birner Hubert","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164101,"kind":"person","name":"Marengere Luc","position":5,"cik":"0001639971","reported_name":"Marengere Luc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164102,"kind":"person","name":"Fischer Stefan","position":6,"cik":"0001398596","reported_name":"Fischer Stefan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164103,"kind":"person","name":"SCHUHSLER HELMUT","position":7,"cik":"0001133921","reported_name":"SCHUHSLER HELMUT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":170326,"kind":"person","name":"Wanless Mark","position":8,"cik":"0001718086","reported_name":"Wanless Mark","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164105,"kind":"person","name":"Leatt Gary","position":9,"cik":"0001718117","reported_name":"Leatt Gary","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-27T18:34:28.000Z","date":"2017-09-19","kind":"other","acquired":true,"shares":227485,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired pursuant to an Agreement and Plan of Merger, dated as of June 30, 2017 (the \"Merger Agreement\"), pursuant to which a wholly-owned subsidiary of the Issuer merged with and into Acer Therapeutics Inc. (\"Acer\"). Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement) of the closing of the Mergers contemplated thereby, the then outstanding shares of Acer's common stock were cancelled and were automatically converted into the right to receive 1 share of the Issuer's common stock for each share of Acer common stock then held by the Reporting Persons. These shares were previously reported on a Form 3 filed by the Reporting Persons on the date of this filing."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were acquired pursuant to an Agreement and Plan of Merger, dated as of June 30, 2017 (the \"Merger Agreement\"), pursuant to which a wholly-owned subsidiary of the Issuer merged with and into Acer Therapeutics Inc. (\"Acer\"). Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement) of the closing of the Mergers contemplated thereby, the then outstanding shares of Acer's common stock were cancelled and were automatically converted into the right to receive 1 share of the Issuer's common stock for each share of Acer common stock then held by the Reporting Persons. These shares were previously reported on a Form 3 filed by the Reporting Persons on the date of this filing."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are directly held by TVM Life Science Ventures VI L.P. (\"TVM VI LP\"). Birner, Schuhsler and Fischer are members of the investment committee of TVM VI Management, a special limited partner of TVM VI LP, with voting and dispositive power over the shares held by TVM VI LP. TVM VI Management, Birner, Schuhsler and Fischer each disclaim beneficial ownership of the shares held by TVM VI LP, except to the extent of any pecuniary interest therein, if any."}],"balance_after":227485,"source":{"system":"sec-edgar","filing":"0001012975-17-000726","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069308/000101297517000726/edgar.xml","form_type":"4"}},{"id":4201069,"issuer":{"id":108116,"kind":"organization","name":"Acer Therapeutics Inc.","symbol":"ACER"},"owners":[{"id":170324,"kind":"person","name":"TVM Life Science Ventures VI GmbH & Co KG","position":1,"cik":"0001599744","reported_name":"TVM Life Science Ventures VI GmbH & Co KG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":170325,"kind":"person","name":"TVM Life Science Ventures VI LP","position":2,"cik":"0001318584","reported_name":"TVM Life Science Ventures VI LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164099,"kind":"person","name":"TVM Life Science Ventures VII L.P.","position":3,"cik":"0001640880","reported_name":"TVM Life Science Ventures VII L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164100,"kind":"person","name":"Birner Hubert","position":4,"cik":"0001398598","reported_name":"Birner Hubert","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164101,"kind":"person","name":"Marengere Luc","position":5,"cik":"0001639971","reported_name":"Marengere Luc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164102,"kind":"person","name":"Fischer Stefan","position":6,"cik":"0001398596","reported_name":"Fischer Stefan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164103,"kind":"person","name":"SCHUHSLER HELMUT","position":7,"cik":"0001133921","reported_name":"SCHUHSLER HELMUT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":170326,"kind":"person","name":"Wanless Mark","position":8,"cik":"0001718086","reported_name":"Wanless Mark","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164105,"kind":"person","name":"Leatt Gary","position":9,"cik":"0001718117","reported_name":"Leatt Gary","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-27T18:34:28.000Z","date":"2017-09-19","kind":"other","acquired":true,"shares":663782,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired pursuant to an Agreement and Plan of Merger, dated as of June 30, 2017 (the \"Merger Agreement\"), pursuant to which a wholly-owned subsidiary of the Issuer merged with and into Acer Therapeutics Inc. (\"Acer\"). Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement) of the closing of the Mergers contemplated thereby, the then outstanding shares of Acer's common stock were cancelled and were automatically converted into the right to receive 1 share of the Issuer's common stock for each share of Acer common stock then held by the Reporting Persons. These shares were previously reported on a Form 3 filed by the Reporting Persons on the date of this filing."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were acquired pursuant to an Agreement and Plan of Merger, dated as of June 30, 2017 (the \"Merger Agreement\"), pursuant to which a wholly-owned subsidiary of the Issuer merged with and into Acer Therapeutics Inc. (\"Acer\"). Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement) of the closing of the Mergers contemplated thereby, the then outstanding shares of Acer's common stock were cancelled and were automatically converted into the right to receive 1 share of the Issuer's common stock for each share of Acer common stock then held by the Reporting Persons. These shares were previously reported on a Form 3 filed by the Reporting Persons on the date of this filing."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by TVM Life Science Ventures VI GmbH & Co. KG (\"TVM VI\"). Hubert Birner (\"Birner\"), Stefan Fischer (\"Fischer\"), and Helmut Schuhsler (\"Schuhsler\") are members of the investment committee of TVM Life Science Ventures Management VI L.P. (\"TVM VI Management\"), a special limited partner of TVM VI, with voting and dispositive power over the shares held by TVM VI. TVM VI Management, Birner, Schuhsler and Fischer each disclaim beneficial ownership of the shares held by TVM VI, except to the extent of any pecuniary interest therein, if any. Birner is a director of the Issuer."}],"balance_after":663782,"source":{"system":"sec-edgar","filing":"0001012975-17-000726","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069308/000101297517000726/edgar.xml","form_type":"4"}},{"id":4413448,"issuer":{"id":12304,"kind":"organization","name":"CoLucid Pharmaceuticals, Inc.","symbol":"CLCD"},"owners":[{"id":164101,"kind":"person","name":"Marengere Luc","position":1,"cik":"0001639971","reported_name":"Marengere Luc","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164099,"kind":"person","name":"TVM Life Science Ventures VII L.P.","position":2,"cik":"0001640880","reported_name":"TVM Life Science Ventures VII L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-01T12:20:12.000Z","date":"2017-03-01","kind":"disposition_to_issuer","acquired":false,"shares":658,"price":10.3,"value":6777.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, these options, which were fully vested, were cancelled in exchange for a cash payment of $46.50 less the per share exercise price multiplied by the number of unexercised options, without interest."}],"balance_after":0,"derivative":{"exercise_price":36.2,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":658},"source":{"system":"sec-edgar","filing":"0000911916-17-000076","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1348649/000091191617000076/edgar.xml","form_type":"4"}},{"id":4413447,"issuer":{"id":12304,"kind":"organization","name":"CoLucid Pharmaceuticals, Inc.","symbol":"CLCD"},"owners":[{"id":164101,"kind":"person","name":"Marengere Luc","position":1,"cik":"0001639971","reported_name":"Marengere Luc","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164099,"kind":"person","name":"TVM Life Science Ventures VII L.P.","position":2,"cik":"0001640880","reported_name":"TVM Life Science Ventures VII L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-01T12:20:12.000Z","date":"2017-03-01","kind":"disposition_to_issuer","acquired":false,"shares":2371,"price":36.88,"value":87442.48,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, these options, which were fully vested, were cancelled in exchange for a cash payment of $46.50 less the per share exercise price multiplied by the number of unexercised options, without interest."}],"balance_after":0,"derivative":{"exercise_price":9.62,"expiration_date":"2026-07-01","underlying":"Common Stock","underlying_shares":2371},"source":{"system":"sec-edgar","filing":"0000911916-17-000076","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1348649/000091191617000076/edgar.xml","form_type":"4"}},{"id":4413446,"issuer":{"id":12304,"kind":"organization","name":"CoLucid Pharmaceuticals, Inc.","symbol":"CLCD"},"owners":[{"id":164101,"kind":"person","name":"Marengere Luc","position":1,"cik":"0001639971","reported_name":"Marengere Luc","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164099,"kind":"person","name":"TVM Life Science Ventures VII L.P.","position":2,"cik":"0001640880","reported_name":"TVM Life Science Ventures VII L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-01T12:20:12.000Z","date":"2017-03-01","kind":"disposition_to_issuer","acquired":false,"shares":8897,"price":40.26,"value":358193.22,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, these options, which provided for full vesting immediately prior to the start of the Issuer's first annual meeting of stockholders following the date of grant, were cancelled in exchange for a cash payment of $46.50 less the per share exercise price multiplied by the number of unexercised options, without interest."}],"balance_after":0,"derivative":{"exercise_price":6.24,"expiration_date":"2026-05-10","underlying":"Common Stock","underlying_shares":8897},"source":{"system":"sec-edgar","filing":"0000911916-17-000076","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1348649/000091191617000076/edgar.xml","form_type":"4"}},{"id":4413445,"issuer":{"id":12304,"kind":"organization","name":"CoLucid Pharmaceuticals, Inc.","symbol":"CLCD"},"owners":[{"id":164101,"kind":"person","name":"Marengere Luc","position":1,"cik":"0001639971","reported_name":"Marengere Luc","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164099,"kind":"person","name":"TVM Life Science Ventures VII L.P.","position":2,"cik":"0001640880","reported_name":"TVM Life Science Ventures VII L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-01T12:20:12.000Z","date":"2017-03-01","kind":"disposition_to_issuer","acquired":false,"shares":1449,"price":38,"value":55062.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, these options, which were fully vested, were cancelled in exchange for a cash payment of $46.50 less the per share exercise price multiplied by the number of unexercised options, without interest."}],"balance_after":0,"derivative":{"exercise_price":8.5,"expiration_date":"2026-01-04","underlying":"Common Stock","underlying_shares":1449},"source":{"system":"sec-edgar","filing":"0000911916-17-000076","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1348649/000091191617000076/edgar.xml","form_type":"4"}},{"id":4413444,"issuer":{"id":12304,"kind":"organization","name":"CoLucid Pharmaceuticals, Inc.","symbol":"CLCD"},"owners":[{"id":164101,"kind":"person","name":"Marengere Luc","position":1,"cik":"0001639971","reported_name":"Marengere Luc","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164099,"kind":"person","name":"TVM Life Science Ventures VII L.P.","position":2,"cik":"0001640880","reported_name":"TVM Life Science Ventures VII L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-01T12:20:12.000Z","date":"2017-03-01","kind":"disposition_to_issuer","acquired":false,"shares":5954,"price":36.5,"value":217321.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, these options, which were fully vested, were cancelled in exchange for a cash payment of $46.50 less the per share exercise price multiplied by the number of unexercised options, without interest."}],"balance_after":0,"derivative":{"exercise_price":10,"expiration_date":"2025-05-05","underlying":"Common Stock","underlying_shares":5954},"source":{"system":"sec-edgar","filing":"0000911916-17-000076","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1348649/000091191617000076/edgar.xml","form_type":"4"}},{"id":4413443,"issuer":{"id":12304,"kind":"organization","name":"CoLucid Pharmaceuticals, Inc.","symbol":"CLCD"},"owners":[{"id":164101,"kind":"person","name":"Marengere Luc","position":1,"cik":"0001639971","reported_name":"Marengere Luc","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164099,"kind":"person","name":"TVM Life Science Ventures VII L.P.","position":2,"cik":"0001640880","reported_name":"TVM Life Science Ventures VII L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-03-01T12:20:12.000Z","date":"2017-03-01","kind":"other","acquired":false,"shares":1545386,"price":46.5,"value":71860449.0,"ownership":{"direct":false,"nature":"By TVM Life Science Ventures VII\nL.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated January 17, 2017 (the \"Merger Agreement\"), by and among CoLucid Pharmaceuticals, Inc. (the \"Issuer\"), Eli Lilly and Company (\"Lilly\") and ProCar Acquisition Corporation, a wholly-owned subsidiary of Lilly, these shares were tendered pursuant to the Merger Agreement in exchange for a cash payment of $46.50 per share in cash, without interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities held directly by TVM Life Science Ventures VII L.P. TVM Life Science Ventures VII (GP) Ltd. is the general partner of TVM Life Science Ventures VII L.P. The reporting person is a managing partner of the investment team of TVM Life Science Venture Capital, which has voting and investment power with respect to these shares. The reporting person may be deemed to be an indirect beneficial owner of the reported securities. The reporting person disclaims any beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. This report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000911916-17-000076","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1348649/000091191617000076/edgar.xml","form_type":"4"}}]}